receiving research grants from Chief Scientist Office, Diabetes UK, European Commission, IQVIA, Juvenile Diabetes Research Foundation and Medical Research Council
BPC-157 has a dose-dependent effect on the spread of fibroblasts in culture and in vivo, causing the cells to both proliferate and migrate faster [1]
Whats more, the study only tested treatment for approximately two months
BPC-157 Arg: A modified variant of BPC-157, enriched with arginine to enhance bioactivity and stability in experimental conditions
Multifunctionality and possible medical application of BPC-157: literature and patent review (2025) Current Pharmaceutical Design (PMC) Sikiric P et al
Musculoskeletal and Connective Tissue Studies Published research has examined BPC-157 in animal models related to tendons, ligaments, and muscle tissue